ASX Appendix 4E Preliminary Final Report

Key points

• Revenue increased by 6% to $131 million
• Loss after tax of $4.4 million compared to profit of $3.06 million last year
• No dividend declared for FY2026
• Expenses rose by 7% due to higher sales and marketing costs
• Cash and cash equivalents decreased by 29% to $5.35 million

Full summary

Vitura Health Ltd reported its financial results for the year ended 30 June 2026, showing total revenues from ordinary activities of $131,158,015, a 6% increase from the previous year. Despite the revenue growth, the company reported a consolidated loss after income tax of $4,406,176, compared to a profit of $3,061,855 in the prior year. The loss was attributed to declining average selling prices, increased competition, and higher costs. The company did not declare a dividend for FY2026. Expenses rose by 7% due to higher sales and marketing costs and personnel expenses. Cash and cash equivalents decreased by 29% to $5,349,206, primarily due to dividend payments and increased bank and merchant charges.